塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/05/19 | 5,715 | 5,820 | 5,657 | 5,810 | +52 | +0.9% | 1,390,000 |
2021/05/18 | 5,740 | 5,811 | 5,711 | 5,758 | -13 | -0.2% | 1,522,400 |
2021/05/17 | 5,777 | 5,819 | 5,741 | 5,771 | +46 | +0.8% | 990,800 |
2021/05/14 | 5,699 | 5,770 | 5,691 | 5,725 | +38 | +0.7% | 1,726,800 |
2021/05/13 | 5,765 | 5,819 | 5,673 | 5,687 | -156 | -2.7% | 1,570,300 |
2021/05/12 | 5,870 | 6,058 | 5,804 | 5,843 | -23 | -0.4% | 2,161,100 |
2021/05/11 | 6,012 | 6,014 | 5,733 | 5,866 | +69 | +1.2% | 3,488,500 |
2021/05/10 | 5,666 | 5,807 | 5,651 | 5,797 | +134 | +2.4% | 1,063,500 |
2021/05/07 | 5,696 | 5,736 | 5,650 | 5,663 | -72 | -1.3% | 1,017,900 |
2021/05/06 | 5,601 | 5,767 | 5,601 | 5,735 | -12 | -0.2% | 1,191,600 |
2021/04/30 | 5,780 | 5,794 | 5,710 | 5,747 | -7 | -0.1% | 892,400 |
2021/04/28 | 5,677 | 5,760 | 5,668 | 5,754 | +71 | +1.2% | 759,300 |
2021/04/27 | 5,730 | 5,749 | 5,671 | 5,683 | -31 | -0.5% | 616,500 |
2021/04/26 | 5,687 | 5,736 | 5,629 | 5,714 | -13 | -0.2% | 687,800 |
2021/04/23 | 5,664 | 5,729 | 5,634 | 5,727 | +51 | +0.9% | 548,900 |
2021/04/22 | 5,604 | 5,683 | 5,591 | 5,676 | +131 | +2.4% | 747,000 |
2021/04/21 | 5,557 | 5,597 | 5,530 | 5,545 | -101 | -1.8% | 970,400 |
2021/04/20 | 5,657 | 5,692 | 5,601 | 5,646 | -24 | -0.4% | 920,600 |
2021/04/19 | 5,612 | 5,740 | 5,547 | 5,670 | -58 | -1% | 1,292,600 |
2021/04/16 | 5,819 | 5,819 | 5,727 | 5,728 | -98 | -1.7% | 767,800 |
2021/04/15 | 5,850 | 5,902 | 5,812 | 5,826 | +64 | +1.1% | 472,000 |
2021/04/14 | 5,757 | 5,804 | 5,717 | 5,762 | -4 | -0.1% | 796,500 |
2021/04/13 | 5,787 | 5,790 | 5,735 | 5,766 | +11 | +0.2% | 695,400 |
2021/04/12 | 5,844 | 5,844 | 5,753 | 5,755 | -95 | -1.6% | 554,700 |
2021/04/09 | 5,820 | 5,898 | 5,787 | 5,850 | +110 | +1.9% | 1,025,300 |
2021/04/08 | 5,793 | 5,796 | 5,709 | 5,740 | -42 | -0.7% | 641,800 |
2021/04/07 | 5,810 | 5,843 | 5,771 | 5,782 | -86 | -1.5% | 944,900 |
2021/04/06 | 5,948 | 5,989 | 5,864 | 5,868 | -93 | -1.6% | 696,400 |
2021/04/05 | 5,958 | 5,997 | 5,953 | 5,961 | +61 | +1% | 474,700 |
2021/04/02 | 5,945 | 5,959 | 5,894 | 5,900 | -27 | -0.5% | 551,700 |
2021/04/01 | 5,972 | 5,993 | 5,902 | 5,927 | -25 | -0.4% | 586,600 |
2021/03/31 | 5,956 | 6,017 | 5,927 | 5,952 | -88 | -1.5% | 910,500 |
2021/03/30 | 6,060 | 6,069 | 5,991 | 6,040 | -16 | -0.3% | 799,300 |
2021/03/29 | 6,056 | 6,099 | 6,009 | 6,056 | +53 | +0.9% | 1,056,300 |
2021/03/26 | 5,979 | 6,058 | 5,971 | 6,003 | +102 | +1.7% | 945,200 |
2021/03/25 | 5,931 | 5,939 | 5,861 | 5,901 | +48 | +0.8% | 621,700 |
2021/03/24 | 5,915 | 5,945 | 5,843 | 5,853 | -151 | -2.5% | 987,600 |
2021/03/23 | 5,935 | 6,023 | 5,933 | 6,004 | +104 | +1.8% | 1,203,700 |
2021/03/22 | 5,909 | 5,944 | 5,874 | 5,900 | -89 | -1.5% | 1,085,200 |
2021/03/19 | 5,922 | 6,009 | 5,915 | 5,989 | +66 | +1.1% | 1,626,200 |
2021/03/18 | 5,888 | 5,943 | 5,865 | 5,923 | +44 | +0.7% | 1,072,200 |
2021/03/17 | 5,808 | 5,883 | 5,729 | 5,879 | -29 | -0.5% | 1,445,100 |
2021/03/16 | 5,988 | 5,995 | 5,844 | 5,908 | -180 | -3% | 1,620,700 |
2021/03/15 | 5,965 | 6,088 | 5,954 | 6,088 | +120 | +2% | 1,074,000 |
2021/03/12 | 6,000 | 6,000 | 5,855 | 5,968 | +18 | +0.3% | 1,824,300 |
2021/03/11 | 5,941 | 5,966 | 5,892 | 5,950 | +25 | +0.4% | 1,232,200 |
2021/03/10 | 5,798 | 5,939 | 5,775 | 5,925 | +186 | +3.2% | 1,508,600 |
2021/03/09 | 5,639 | 5,745 | 5,612 | 5,739 | +167 | +3% | 1,010,500 |
2021/03/08 | 5,505 | 5,615 | 5,500 | 5,572 | +112 | +2.1% | 853,800 |
2021/03/05 | 5,415 | 5,464 | 5,372 | 5,460 | +31 | +0.6% | 993,000 |
1051~
1100
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム